Intuitive Surgical, Inc. $ISRG Shares Sold by Connor Clark & Lunn Investment Management Ltd.

Connor Clark & Lunn Investment Management Ltd. decreased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 98.7% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 714 shares of the medical equipment provider’s stock after selling 52,789 shares during the quarter. Connor Clark & Lunn Investment Management Ltd.’s holdings in Intuitive Surgical were worth $388,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the stock. Princeton Global Asset Management LLC acquired a new position in shares of Intuitive Surgical in the 2nd quarter worth $30,000. TD Capital Management LLC boosted its position in shares of Intuitive Surgical by 300.0% in the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 45 shares during the period. 1248 Management LLC purchased a new position in Intuitive Surgical in the 1st quarter worth about $30,000. Bank of Jackson Hole Trust raised its holdings in Intuitive Surgical by 70.5% during the 1st quarter. Bank of Jackson Hole Trust now owns 75 shares of the medical equipment provider’s stock worth $37,000 after buying an additional 31 shares during the period. Finally, First Command Advisory Services Inc. raised its holdings in Intuitive Surgical by 3,750.0% during the 2nd quarter. First Command Advisory Services Inc. now owns 77 shares of the medical equipment provider’s stock worth $42,000 after buying an additional 75 shares during the period. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Down 2.2%

Shares of NASDAQ:ISRG opened at $552.23 on Friday. The firm has a fifty day moving average of $489.85 and a two-hundred day moving average of $504.10. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00. The firm has a market capitalization of $197.96 billion, a P/E ratio of 73.05, a price-to-earnings-growth ratio of 4.94 and a beta of 1.62.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. The business had revenue of $2.51 billion for the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. Intuitive Surgical’s revenue for the quarter was up 22.9% compared to the same quarter last year. During the same period in the prior year, the business posted $1.84 earnings per share. Equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the stock. Hsbc Global Res raised shares of Intuitive Surgical to a “strong-buy” rating in a research report on Thursday, October 23rd. Sanford C. Bernstein reaffirmed an “outperform” rating and issued a $685.00 price objective on shares of Intuitive Surgical in a research note on Tuesday, October 21st. Leerink Partners boosted their target price on shares of Intuitive Surgical from $593.00 to $600.00 and gave the company an “outperform” rating in a research note on Wednesday, October 22nd. BTIG Research raised their target price on Intuitive Surgical from $529.00 to $589.00 and gave the stock a “buy” rating in a research report on Wednesday, October 22nd. Finally, Truist Financial set a $620.00 price target on Intuitive Surgical and gave the company a “buy” rating in a report on Wednesday, October 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $608.92.

Insider Activity at Intuitive Surgical

In other news, EVP Brian Edward Miller sold 3,500 shares of Intuitive Surgical stock in a transaction dated Monday, November 10th. The stock was sold at an average price of $575.00, for a total transaction of $2,012,500.00. Following the completion of the sale, the executive vice president directly owned 5,758 shares in the company, valued at $3,310,850. The trade was a 37.81% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Fredrik Widman sold 2,067 shares of the business’s stock in a transaction that occurred on Wednesday, November 5th. The shares were sold at an average price of $550.00, for a total value of $1,136,850.00. Following the completion of the sale, the vice president directly owned 473 shares of the company’s stock, valued at approximately $260,150. The trade was a 81.38% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 116,164 shares of company stock worth $61,916,172. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.